Yie; Junming

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yie; Junming.The latest application filed is for "cell-based bioidentity test for insulin".

Company Profile

6.7.11

Yie; Junming - Warren NJ
Yie; Junming - Thousand Oaks CA US
Yie; Junming - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antigen binding proteins that bind to a complex comprising .beta.-Klotho and an FGF receptor Grant 11,248,052 - Li , et al. February 15, 2	2022-02-15
Cell-based Bioidentity Test For Insulin App 20220026414 - Yie; Junming	2022-01-27
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20220025059 - YIE; Junming ; et al.	2022-01-27
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Grant 11,046,774 - Yie , et al. June 29, 2	2021-06-29
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (gipr) App 20210154318 - CHENG; Yuan ; et al.	2021-05-27
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) Grant 10,905,772 - Cheng , et al. February 2, 2	2021-02-02
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In App 20190276546 - Yie; Junming ; et al.	2019-09-12
Human Antigen Binding Proteins That Bind to a Complex Comprising Beta-Klotho and an FGF Receptor App 20190248906 - LI; Yang ; et al.	2019-08-15
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Grant 10,294,303 - Yie , et al.	2019-05-21
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (gipr) App 20180311372 - CHENG; Yuan ; et al.	2018-11-01
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20170275370 - YIE; Junming ; et al.	2017-09-28
Human Antigen Binding Proteins That Bind To a Complex Comprising beta-Klotho and an FGF Receptor App 20170183412 - LI; Yang ; et al.	2017-06-29
Human antigen binding proteins that bind to a complex comprising .beta.-Klotho and an FGF receptor Grant 9,574,002 - Li , et al. February 21, 2	2017-02-21
Human Antigen Binding Proteins That Bind To A Complex Comprising Beta-klotho And An Fgf Receptor App 20120328616 - LI; YANG ; et al.	2012-12-27
Antibodies To Myostatin App 20110091455 - Chin; Eva Rose ; et al.	2011-04-21
Antibodies to myostatin Grant 7,807,159 - Chin , et al. October 5, 2	2010-10-05
Antibodies to myostatin App 20060263354 - Chin; Eva Rose ; et al.	2006-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.